Therefore, it is speculated that oridonin may regulate the TP53/TCF4 axis by increasing ROS production and disrupting Ca2+ homeostasis, thereby inducing sustained ER stress and inhibiting tumor progression [61]. Here, TP53 is linked to neoplasm.